This is what really concerns me. We just went d
Post# of 36537
We just went down to .77 and we are having bids in the .76 range already.
We can talk about the work they are going to do with the virus, but that's a 4 month process probably and right now, they need funding to keep on track.
This S-1 is critical at this point to fund everything. They need to put out some news on what is going on with everything else. It can't just be about the work on the virus.
As was mentioned before, they have a team that handles everything that is going on in Generex / NGIO. What's happening with the S-1 that's supposed to be put in this week for NGIO? That's critical.
What's going on with funding? What's going on with the MSO? With sales?
Everything cannot be dependent on China.